Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study of Omecamtiv Mecarbil in healthy volunteers conducted by Cytokinetics, related to heart failure research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• omecamtiv mecarbil (omecamtiv mecarbil)

Snippet

Sponsor: Cytokinetics | Conditions: Heart Failure | Phase 1 | Status: COMPLETED